RxDoctor Payments Data

Jessica Valdez

Physician Assistant · Phoenix, AZNPI 1073132940

Payments from drug & device makers

$3,659in general payments, 2019–2025

Across 163 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$459
  • Boehringer Ingelheim$315
  • Lilly USA, LLC$287
  • Boston Scientific$269
  • Amgen$245
  • plus $951 from 22 others

What the payments were for

  • Food & beverage$3,59998%
  • Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,659 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide68$141,630
FarxigaDapagliflozin Propanediol71$113,971
JardianceEmpagliflozin46$82,707
OzempicSemaglutide23$57,488
MyrbetriqMirabegron34$42,275
JanuviaSitagliptin Phosphate24$37,472
VascepaIcosapent Ethyl37$36,447
TradjentaLinagliptin32$35,723
Repatha SureclickEvolocumab23$29,881
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog25$29,076
Soliqua 100-33Insulin Glargine/Lixisenatide22$21,053
EliquisApixaban14$20,684
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$14,516
LinzessLinaclotide11$12,696
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$9,794

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$287$141,63068 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,133$128,48785 claims
Boehringer IngelheimJardiance, Tradjenta$315$118,43078 claims
Novo NordiskOzempic$459$57,48823 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$94$21,05322 claims
PfizerEliquis$69$20,68414 claims
AbbVieLinzess$55$12,69611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →